60 related articles for article (PubMed ID: 22345342)
1. The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study.
García-Compeán D; Jáquez-Quintana JO; Lavalle-González FJ; Reyes-Cabello E; González-González JA; Muñoz-Espinosa LE; Vázquez-Elizondo G; Villarreal-Pérez JZ; Maldonado-Garza HJ
Ann Hepatol; 2012; 11(2):240-8. PubMed ID: 22345342
[TBL] [Abstract][Full Text] [Related]
2. Subclinical diabetes confirmed by 75-g OGTT influence on the prognosis of decompensated cirrhosis.
Kang SH; Kim MY; Han SK; Baik SK
J Gastroenterol Hepatol; 2024 Jan; 39(1):172-179. PubMed ID: 37697655
[TBL] [Abstract][Full Text] [Related]
3. Impacts of the development of acute-on-chronic liver failure and bacterial infections on β-cell function and glucose homeostasis in patients with liver cirrhosis.
Liu Y; Hu H; Li C; Zhang Y; Li M; Lu T; Wu Y; Yang Y; Li Y; Yang F; Shi X; Lin S
Dig Liver Dis; 2024 Apr; 56(4):648-655. PubMed ID: 37758609
[TBL] [Abstract][Full Text] [Related]
4. Hepatogenous Diabetes as Compared to Type-2 Diabetes Mellitus and Non-diabetes in Patients With Liver Cirrhosis: Magnitude, Characteristics, and Implications.
Maji T; Mahto M; Kumar S; Anand U; Priyadarshi RN; Arya R; Kumar R
J Clin Exp Hepatol; 2024; 14(5):101411. PubMed ID: 38699514
[TBL] [Abstract][Full Text] [Related]
5. Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.
García-Compeán D; Jáquez-Quintana JO; Lavalle-González FJ; González-González JA; Muñoz-Espinosa LE; Villarreal-Pérez JZ; Maldonado-Garza HJ
World J Gastroenterol; 2014 Jun; 20(22):7011-8. PubMed ID: 24944496
[TBL] [Abstract][Full Text] [Related]
6. Liver disease and diabetes: association, pathophysiology, and management.
Ahmadieh H; Azar ST
Diabetes Res Clin Pract; 2014 Apr; 104(1):53-62. PubMed ID: 24485856
[TBL] [Abstract][Full Text] [Related]
7. [Diabetes in liver cirrhosis].
García-Compeán D; Jáquez-Quintana JO; González-González JA; Lavalle-González FJ; Villarreal-Pérez JZ; Maldonado-Garza HJ
Gastroenterol Hepatol; 2013; 36(7):473-82. PubMed ID: 23628170
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases.
Chung W; Promrat K; Wands J
World J Hepatol; 2020 Sep; 12(9):533-557. PubMed ID: 33033564
[TBL] [Abstract][Full Text] [Related]
9. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G
Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus in patients with cirrhosis: clinical implications and management.
Elkrief L; Rautou PE; Sarin S; Valla D; Paradis V; Moreau R
Liver Int; 2016 Jul; 36(7):936-48. PubMed ID: 26972930
[TBL] [Abstract][Full Text] [Related]
11. Effects of Liver Fibrosis on Islet Function in Patients with Chronic Hepatitis B Complicated with Impaired Fasting Glucose.
Lu Y; Gou W; Zhang HF; Li YY
Int J Gen Med; 2023; 16():5161-5173. PubMed ID: 38021063
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review.
Chan WK; Chuah KH; Rajaram RB; Lim LL; Ratnasingam J; Vethakkan SR
J Obes Metab Syndr; 2023 Sep; 32(3):197-213. PubMed ID: 37700494
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer.
Manilla V; Santopaolo F; Gasbarrini A; Ponziani FR
Nutrients; 2023 May; 15(11):. PubMed ID: 37299482
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-products as mediators of the aberrant crosslinking of extracellular matrix in scarred liver tissue.
Lyu C; Kong W; Liu Z; Wang S; Zhao P; Liang K; Niu Y; Yang W; Xiang C; Hu X; Li X; Du Y
Nat Biomed Eng; 2023 Nov; 7(11):1437-1454. PubMed ID: 37037967
[TBL] [Abstract][Full Text] [Related]
15. Hepatogenous diabetes: Knowledge, evidence, and skepticism.
Kumar R; García-Compeán D; Maji T
World J Hepatol; 2022 Jul; 14(7):1291-1306. PubMed ID: 36158904
[TBL] [Abstract][Full Text] [Related]
16. Hepatogenous Diabetes - A Report from Central India.
Vasepalli P; Noor MT; Thakur BS
J Clin Exp Hepatol; 2022; 12(2):312-318. PubMed ID: 35535090
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives.
García-Compeán D; Orsi E; Kumar R; Gundling F; Nishida T; Villarreal-Pérez JZ; Del Cueto-Aguilera ÁN; González-González JA; Pugliese G
World J Gastroenterol; 2022 Feb; 28(8):775-793. PubMed ID: 35317103
[TBL] [Abstract][Full Text] [Related]
18. Hepatogenous Diabetes: A Primer.
Nath P; Anand AC
J Clin Exp Hepatol; 2021; 11(5):603-615. PubMed ID: 34511822
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus increases liver transplant-free mortality in patients with cirrhosis: A systematic review and meta-analysis.
Liu ZJ; Yan YJ; Weng HL; Ding HG
World J Clin Cases; 2021 Jul; 9(20):5514-5525. PubMed ID: 34307604
[TBL] [Abstract][Full Text] [Related]
20. Clinical study of abnormal glucose metabolism and insulin resistance in patients with liver cirrhosis.
Li H; Sun F; Yang W; Huang M; Pan C; Lin C
Am J Transl Res; 2021; 13(4):3522-3528. PubMed ID: 34017531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
